RESULTS OF COMPLEX TREATMENT OF CLIMACTERIC SYNDROME ASSOCIATED WITH DIABETES MELLITUS TYPE 2
Keywords:
diabetes, chronic hyperglycemia, metabolic diseases, insulin resistanceAbstract
Diabetes mellitus (DM) is a group of metabolic diseases characterized by hyperglycemia. The vast majority of diabetes cases are among the two largest etiopathogenetic categories: diabetes mellitus type 1 (DM-1) with absolute insulin deficiency and type 2 diabetes mellitus (DM-2), in which chronic hyperglycemia develops through a combination of insulin resistance and inadequate compensatory insulin secretion answers [3, 14]. With regard to the climacteric period, the greatest clinical significance has DM-2, which is 90-95% of all cases of diabetes. The incidence of diabetes is significantly increased in women 45-50 years of age and older. Note that women over 45 years of age have diabetes in 2 times more than men [6, 8].
References
1. Volotovskaya AV, Kozlovskaya LE. Fyzycheskye faktorы v lechenyy sakharnoho dyabeta y eho oslozhnenyy. Fyzyoterapyya, bal'neolohyya y reabylytatsyya. 2013;(2):34-42.
2. Arteaga Urzúa E. Menopause and cardiovascular risk. Rev Med Chil. 2016 Nov;144(11):1375-1376.
3. Czupryniak L, redactor. Nowoczesna diabetologia w praktyce. Warszawa: Bonnier Business Polska; 2014. 59 s.
4. De Lorenzi DR. Evaluation of quality of life in climacterium. Rev Bras Ginecol Obstet. 2008 Mar;30(3):103-6.
5. Karvonen-Gutierrez CA, Park SK, Kim C. Diabetes and menopause. Curr Diab Rep. 2016 Apr;16(4):20.
6. Mauvais-Jarvis F. Epidemiology of gender differences in diabetes and obesity. Adv Exp Med Biol. 2017;1043:3-8.
7. Muka T, Asllanaj E, Avazverdi N, Jaspers L, Stringa N, Milic J, et al. Age at natural menopause and risk of type 2 diabetes: a prospective cohort study. Diabetologia. 2017 Oct;60(10):1951-1960.
8. Muñoz Enciso JM, Rosales Aujang E, Arias Ulloa R. Metabolic disorders in women during climacterium. Ginecol Obstet Mex. 2013 Apr;81(4):186-9.
9. Nanayakkara N, Ranasinha S, Gadowski A, Heritier S, Flack JR, Wischer N, et al. Age, age at diagnosis and diabetes duration are all associated with vascular complications in type 2 diabetes. J Diabetes Complications. 2018 Mar;32(3):279-290.
10. Niland P, Lyons AC. Uncertainty in medicine: meanings of menopause and hormone replacement therapy in medical textbooks. Soc Sci Med. 2011 Oct;73(8):1238-45.
11. Stuenkel CA. Menopause, hormone therapy and diabetes. Climacteric. 2017 Feb;20(1):11-21.
12. Taylor M. Complementary and alternative approaches to menopause. Endocrinol Metab Clin North Am. 2015 Sep;44(3):619-48. 1
13. Tonob D, Melby MK. Broadening our perspectives on complementary and alternative medicine for menopause: A narrative review. Maturitas. 2017 May;99:79-85.
14. Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018 Feb;14(2):88-98.
2. Arteaga Urzúa E. Menopause and cardiovascular risk. Rev Med Chil. 2016 Nov;144(11):1375-1376.
3. Czupryniak L, redactor. Nowoczesna diabetologia w praktyce. Warszawa: Bonnier Business Polska; 2014. 59 s.
4. De Lorenzi DR. Evaluation of quality of life in climacterium. Rev Bras Ginecol Obstet. 2008 Mar;30(3):103-6.
5. Karvonen-Gutierrez CA, Park SK, Kim C. Diabetes and menopause. Curr Diab Rep. 2016 Apr;16(4):20.
6. Mauvais-Jarvis F. Epidemiology of gender differences in diabetes and obesity. Adv Exp Med Biol. 2017;1043:3-8.
7. Muka T, Asllanaj E, Avazverdi N, Jaspers L, Stringa N, Milic J, et al. Age at natural menopause and risk of type 2 diabetes: a prospective cohort study. Diabetologia. 2017 Oct;60(10):1951-1960.
8. Muñoz Enciso JM, Rosales Aujang E, Arias Ulloa R. Metabolic disorders in women during climacterium. Ginecol Obstet Mex. 2013 Apr;81(4):186-9.
9. Nanayakkara N, Ranasinha S, Gadowski A, Heritier S, Flack JR, Wischer N, et al. Age, age at diagnosis and diabetes duration are all associated with vascular complications in type 2 diabetes. J Diabetes Complications. 2018 Mar;32(3):279-290.
10. Niland P, Lyons AC. Uncertainty in medicine: meanings of menopause and hormone replacement therapy in medical textbooks. Soc Sci Med. 2011 Oct;73(8):1238-45.
11. Stuenkel CA. Menopause, hormone therapy and diabetes. Climacteric. 2017 Feb;20(1):11-21.
12. Taylor M. Complementary and alternative approaches to menopause. Endocrinol Metab Clin North Am. 2015 Sep;44(3):619-48. 1
13. Tonob D, Melby MK. Broadening our perspectives on complementary and alternative medicine for menopause: A narrative review. Maturitas. 2017 May;99:79-85.
14. Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018 Feb;14(2):88-98.
Downloads
Published
2019-06-05
How to Cite
Павловська, М. О. (2019). RESULTS OF COMPLEX TREATMENT OF CLIMACTERIC SYNDROME ASSOCIATED WITH DIABETES MELLITUS TYPE 2. PRECARPATHIAN BULLETIN OF THE SHEVCHENKO SCIENTIFIC SOCIETY Pulse, (8(44), 23–29. Retrieved from https://pvntsh.nung.edu.ua/index.php/pulse/article/view/497
Issue
Section
КЛІНІЧНА МЕДИЦИНА
